Musclepharm Corp
MSLPQ
Revenue
13.10M
▲3.06M▲30.46%
3 Months ChangeAssets
11.98M
▲1.25M▲11.62%
3 Months ChangeLiabilities
50.03M
▲7.11M▲16.57%
3 Months ChangeFree Cash Flow
94.00k
▲4.93M▲101.94%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2023-08-31
Form 8-K
ID: 0001493152-23-031353
2023-07-19
Form 8-K
ID: 0001493152-23-024915
2023-03-10
Form 8-K
ID: 0001493152-23-007244
2023-01-11
Form 8-K
ID: 0001415684-23-000003
2023-01-11
Form 8-K
ID: 0001415684-23-000002
2023-01-09
Form 8-K
ID: 0001415684-23-000001
2022-09-29
Form 8-K
ID: 0001493152-22-027167
2022-09-19
Form 8-K
ID: 0001493152-22-026142
2022-08-23
Form 8-K
ID: 0001493152-22-023847
2022-08-22
Form 8-K
ID: 0001493152-22-023755